Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).

Authors

Daniel Vargas Pivato de Almeida

Daniel Vargas Almeida

BP-A Beneficencia Portuguesa de São Paulo, São Paulo, Brazil

Daniel Vargas Almeida , Cleyton Z. Oliveira , Andrey Soares , RODRIGO COUTINHO MARIANO , Denis L Jardim , Diogo Assed Bastos , Fernando C. Maluf , Gustavo Werutsky , Fernando Sabino M Monteiro , Vinicius Carrera Souza , Guillermo de Velasco , Andre P. Fay , Andre Deeke Sasse , Fabio A. B. Schutz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4579)

DOI

10.1200/JCO.2019.37.15_suppl.4579

Abstract #

4579

Poster Bd #

405

Abstract Disclosures

Similar Posters

Poster

2020 Genitourinary Cancers Symposium

Adjuvant therapy in high-risk renal cell cancer: A systematic review and cumulative meta-analysis.

Adjuvant therapy in high-risk renal cell cancer: A systematic review and cumulative meta-analysis.

First Author: Rabbia Siddiqi

Poster

2018 Genitourinary Cancers Symposium

Adjuvant antiangiogenic agents in post-nephrectomy renal cell carcinoma (RCC): A systematic review and meta-analysis.

Adjuvant antiangiogenic agents in post-nephrectomy renal cell carcinoma (RCC): A systematic review and meta-analysis.

First Author: Mohamad Bassam Sonbol